Cavaleri Rocco, Schabrun Siobhan M, Te Maxine, Chipchase Lucy S
Western Sydney University, Brain Rehabilitation and Neuroplasticity Unit, School of Science and Health, NSW 2560, Australia.
Western Sydney University, Brain Rehabilitation and Neuroplasticity Unit, School of Science and Health, NSW 2560, Australia.
J Hand Ther. 2016 Jan-Mar;29(1):3-11. doi: 10.1016/j.jht.2015.10.004. Epub 2015 Nov 6.
Systematic review with meta-analysis.
Although corticosteroid injections are often cited as best practice in the treatment of de Quervain's disease, no reviews have compared their effectiveness to a multimodal definition of hand therapy.
To compare the effectiveness of corticosteroid injections with that of i) hand therapy alone and ii) combined hand therapy/corticosteroid injection approaches in the treatment of de Quervain's disease.
Searches of key databases were performed to identify experimental studies published between January 1950 and November 2014. Outcome measures included treatment success, pain, quality of life, and function.
Both corticosteroid injections and hand therapy improved pain and function from baseline, but between-group differences were not significant (across 6 studies). However, significantly more participants were treated successfully when combined orthosis/corticosteroid injection approaches were compared to i) orthoses (RR 0.53, 95% CI 0.35-0.80) and ii) injections alone (RR 0.76, 95% CI 0.64-0.89).
Combined orthosis/corticosteroid injection approaches are more effective than either intervention alone in the treatment of de Quervain's disease.
1a.
系统评价与荟萃分析。
尽管皮质类固醇注射常被视为治疗桡骨茎突狭窄性腱鞘炎的最佳方法,但尚无综述将其有效性与多模式手部治疗进行比较。
比较皮质类固醇注射与以下两种方法在治疗桡骨茎突狭窄性腱鞘炎方面的有效性:i)单纯手部治疗;ii)手部治疗/皮质类固醇注射联合方法。
检索主要数据库,以识别1950年1月至2014年11月发表的实验研究。结局指标包括治疗成功率、疼痛、生活质量和功能。
皮质类固醇注射和手部治疗均使疼痛和功能较基线有所改善,但组间差异不显著(6项研究)。然而,与i)矫形器(RR 0.53,95%CI 0.35 - 0.80)和ii)单纯注射(RR 0.76,95%CI 0.64 - 0.89)相比,矫形器/皮质类固醇注射联合方法成功治疗的参与者显著更多。
在治疗桡骨茎突狭窄性腱鞘炎方面,矫形器/皮质类固醇注射联合方法比单独任何一种干预措施都更有效。
1a。